We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,044 hedge funds and large institutions have $55.2B invested in Thermo Fisher Scientific in 2016 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 332 increasing their positions, 458 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more funds holding in top 10

Funds holding in top 10: 7893 (+15)

13% more call options, than puts

Call options by funds: $226M | Put options by funds: $201M

7% more capital invested

Capital invested by funds: $51.5B → $55.2B (+$3.71B)

0.13% less ownership

Funds ownership: 88.79%88.67% (-0.13%)

2% less first-time investments, than exits

New positions opened: 64 | Existing positions closed: 65

1% less funds holding

Funds holding: 1,0551,044 (-11)

28% less repeat investments, than reductions

Existing positions increased: 332 | Existing positions reduced: 458

Holders
1,044
Holders Change
-11
Holders Change %
-1.04%
% of All Funds
27.85%
Holding in Top 10
93
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+19.23%
% of All Funds
2.48%
New
64
Increased
332
Reduced
458
Closed
65
Calls
$226M
Puts
$201M
Net Calls
+$25.2M
Net Calls Change
-$33.8M
Name Holding Trade Value Shares
Change
Change in
Stake
CWM
626
Confluence Wealth Management
Oregon
$1.67M -$50.7K -329 -3%
SAM
627
Symphony Asset Management
California
$1.66M +$1.61M +10,416 New
BIM
628
Baldwin Investment Management
Pennsylvania
$1.64M -$38.5K -250 -2%
TMAM
629
Tokio Marine Asset Management
Japan
$1.62M -$258K -1,673 -14%
MSV
630
MN Services Vermogensbeheer
Netherlands
$1.62M +$22K +143 +1%
MCP
631
Mirador Capital Partners
California
$1.6M -$21.1K -137 -1%
Daiwa Securities Group
632
Daiwa Securities Group
Japan
$1.59M
MAM
633
Meeder Asset Management
Ohio
$1.58M -$674K -4,371 -31%
TAM
634
Tealwood Asset Management
Minnesota
$1.56M +$1.51M +9,808 New
ECM
635
EagleClaw Capital Management
Massachusetts
$1.54M +$23.1K +150 +2%
PFM
636
PacWest Financial Management
Arizona
$1.53M -$58.6K -380 -4%
AIP
637
Ameritas Investment Partners
Nebraska
$1.53M +$253K +1,645 +21%
JGGDR
638
JGP Global Gestao de Recursos
Brazil
$1.52M +$258K +1,676 +21%
CAM
639
Capstone Asset Management
Texas
$1.5M +$136K +885 +10%
EP
640
Edgestream Partners
New Jersey
$1.5M +$1.45M +9,422 New
FC
641
Forte Capital
New York
$1.5M -$61.6K -400 -4%
EMR
642
Errol M. Rudman
$1.5M
DVM
643
Dreman Value Management
Florida
$1.49M -$72.1K -468 -5%
DY
644
Dowling & Yahnke
California
$1.49M +$38.8K +252 +3%
BBHC
645
Brown Brothers Harriman & Co
New York
$1.47M -$297K -1,928 -17%
AT
646
Argent Trust
Texas
$1.46M -$4.93K -32 -0.3%
RIM
647
Regent Investment Management
Kentucky
$1.46M
FCFC
648
First Commonwealth Financial Corp
Pennsylvania
$1.46M -$207K -1,346 -13%
DCM
649
Dupont Capital Management
Delaware
$1.46M +$1.41M +9,160 New
LCM
650
Laurion Capital Management
New York
$1.45M +$1.07M +6,962 +320%

TMO Hedge Fund Activity: Q3 2016 in Review

1,044 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2016, worth a combined $55.2B — up 7.2% from $51.5B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of TMO and 64 opened new positions — a net loss of 1 holder — while 458 trimmed existing stakes and 332 added.

The largest buyer was Winslow Capital Management, opening a new position worth an estimated $290M. The largest seller was Capital Research Global Investors, cutting an estimated $250M.

  • 1,044 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2016, down from 1,055 in Q2 2016.
  • Funds reported $55.2B of Thermo Fisher Scientific stock for Q3 2016, up 7.2% quarter-over-quarter.
  • 64 funds opened new Thermo Fisher Scientific positions in Q3 2016 and 65 closed out, a net change of -1 holder.
  • The largest Thermo Fisher Scientific buyer in Q3 2016 was Winslow Capital Management, an estimated $290M added.
  • The largest Thermo Fisher Scientific seller in Q3 2016 was Capital Research Global Investors, an estimated $250M sold.

Based on aggregated 13F filings for Q3 2016.